Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$351K Sell
25,241
-234,675
-90% -$3.66M ﹤0.01% 1325
2026
Q1
$3.27M Buy
259,916
+47,999
+23% +$486K 0.03% 587
2025
Q4
$1.84M Buy
211,917
+111,486
+111% +$968K 0.01% 805
2025
Q3
$942K Buy
+100,431
New +$936K 0.01% 985
2025
Q2
Sell
-200,014
Closed -$1.74M 1420
2025
Q1
$1.74M Buy
200,014
+165,376
+477% +$1.66M 0.02% 741
2024
Q4
$289K Sell
34,638
-162,478
-82% -$1.2M ﹤0.01% 1288
2024
Q3
$1.17M Buy
+197,116
New +$1.1M 0.01% 925
2024
Q2
Sell
-45,820
Closed -$249K 1472
2024
Q1
$249K Buy
+45,820
New +$292K ﹤0.01% 1303
2023
Q2
Sell
-85,373
Closed -$1.35M 1808
2023
Q1
$1.35M Buy
+85,373
New +$1.48M 0.01% 1032
2022
Q4
Sell
-50,492
Closed -$989K 1590
2022
Q3
$989K Buy
50,492
+25,712
+104% +$561K 0.01% 1111
2022
Q2
$434K Sell
24,780
-109,657
-82% -$1.98M 0.01% 1409
2022
Q1
$2.48M Buy
+134,437
New +$2.66M 0.03% 680
2021
Q4
Sell
-27,676
Closed -$519K 2120
2021
Q3
$519K Buy
27,676
+16,389
+145% +$345K 0.01% 1353
2021
Q2
$233K Sell
11,287
-1,218
-10% -$23.5K ﹤0.01% 1897
2021
Q1
$209K Sell
12,505
-15,596
-55% -$263K ﹤0.01% 1851
2020
Q4
$415K Buy
+28,101
New +$357K ﹤0.01% 1359
2020
Q3
Sell
-13,410
Closed -$147K 1695
2020
Q2
$147K Buy
13,410
+3,194
+31% +$33K ﹤0.01% 1581
2020
Q1
$78K Buy
+10,216
New +$87.3K ﹤0.01% 918
2019
Q3
Sell
-23,980
Closed -$366K 1302
2019
Q2
$366K Buy
+23,980
New +$383K 0.01% 597

Other funds holding ADTN

Michael Gelband's ADTN Position: Q2 2026 in Review

Michael Gelband reduced its Adtran (ADTN) stake by 90% in Q2 2026, selling an estimated $3.66M and leaving 25,241 shares worth $351K. The position accounts for ﹤0.01% of the portfolio, ranked #1325.

Michael Gelband first reported a position in ADTN in Q2 2019 and has held it in 19 quarters since. The position peaked at $3.27M in Q1 2026. 247 funds tracked by Wall St. Rank hold ADTN as of Q2 2026.

  • Michael Gelband held 25,241 shares of Adtran worth $351K as of Q2 2026.
  • Michael Gelband sold 234,675 Adtran shares in Q2 2026, an estimated $3.66M.
  • Adtran made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1325 holding.
  • Michael Gelband first reported a position in Adtran in Q2 2019 and has held it in 19 quarters since.
  • Michael Gelband's Adtran position peaked at $3.27M in Q1 2026.
  • 247 funds tracked by Wall St. Rank held Adtran as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.